Evidence map›Paper›PMID 30244333›Full record

ArticleObesity surgery2019

Circulating Endocannabinoids Are Reduced Following Bariatric Surgery and Associated with Improved Metabolic Homeostasis in Humans.

Shahar Azar, Shiri Sherf-Dagan, Alina Nemirovski, Muriel Webb, Asnat Raziel, Andrei Keidar, David Goitein, Nasser Sakran, Oren Shibolet, Joseph Tam and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Obesity surgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 34 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Hepatic targeting of the centrally active cannabinoid 1 receptor (CBJournal of controlled release : official journal of the Controlled Release Society · 2023
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Shahar AzarObesity and Metabolism Laboratory, The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Shiri Sherf-DaganDepartment Gastroenterology, Tel-Aviv Medical Center, Tel-Aviv, Israel.ORCID 0000-0003-1225-7551
Alina NemirovskiObesity and Metabolism Laboratory, The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Muriel WebbDepartment Gastroenterology, Tel-Aviv Medical Center, Tel-Aviv, Israel.
Asnat RazielAssia Medical Group, Assuta Medical Center, Tel-Aviv, Israel.
Andrei KeidarDepartment of General Surgery, Assuta Ashdod Public Hospital, affiliated to the Ben-Gurion University, Beer-Sheba, Israel.
David GoiteinSackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Nasser SakranAssia Medical Group, Assuta Medical Center, Tel-Aviv, Israel.
Oren ShiboletDepartment Gastroenterology, Tel-Aviv Medical Center, Tel-Aviv, Israel.
Joseph TamObesity and Metabolism Laboratory, The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel. yossit@ekmd.huji.ac.il.
Shira Zelber-SagiDepartment Gastroenterology, Tel-Aviv Medical Center, Tel-Aviv, Israel. zelbersagi@bezeqint.net.
Hebrew University of Jerusalem · ILTel Aviv University · ILAssuta Medical Center · ILTechnion – Israel Institute of Technology · ILTel Aviv Sourasky Medical Center · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe endocannabinoid (eCB) system plays a key role in the development of obesity and its comorbidities. Limited information exists on the changes in circulating eCBs following bariatric surgery.

objectivesThis study aims to (i) assess the circulating levels of eCBs and related molecules and (ii) examine the association between their levels and numerous clinical/metabolic features pre- and post-operatively.

methodsSixty-five morbidly obese patients (age 42.78 ± 9.27 years; BMI 42.00 ± 5.01 kg/m

resultsLevels of 2-AG, AEA, and AA were reduced post operatively with no differences in serum OEA levels. The delta changes in eCB levels between pre- and post-operation were correlated with the delta of different metabolic parameters. Positive correlations were found between delta AA and waist circumference (WC) (r = 0.28, P < 0.05), free fat mass (r = 0.26, P < 0.05), SteatoTest score (r = 0.45, P < 0.05), and ALT (r = 0.32, P < 0.05). Delta AEA levels positively correlated with WC (r = 0.30, P < 0.05). Delta 2-AG levels positively correlated with total cholesterol (r = 0.27, P < 0.05), triglycerides (r = 0.55, P < 0.05), and SteatoTest score (r = 0.27, P < 0.05). Delta OEA levels negatively correlated with fasting glucose levels (r = - 0.27, P < 0.05).

conclusionsThis study provides compelling evidence that LSG surgery induces reductions in the circulating 2-AG, AEA, and AA levels, and that these changes are associated with clinical benefits related to the surgery including reduced fat mass, hepatic steatosis, glucose, and improved lipid profile.

Indexed as

Bariatric SurgeryAdultBiomarkersEndocannabinoidsFemaleFollow-Up StudiesGastrectomyHomeostasisHumansMaleMiddle AgedObesity, MorbidPostoperative PeriodPrognosisWaist CircumferenceBiomarkersEndocannabinoidsEndocannabinoidsLaparoscopic sleeve gastrectomyMetabolic parametersObesity

Identifiers

PMID30244333
OpenAlexW2892406030

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.